Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Another ECJ fudge as GSK parallel trade case rumbles on

This article was originally published in Scrip

Executive Summary

Appeal, cross-appeal, response to the cross appeal, appeal, appeal, appeal – and this has only touched on the very the start of the Judgement handed down recently by the European Court of Justice (ECJ) in the GlaxoSmithKline Services v Commission parallel trade case. It is clear from the numerous forms of order sought in this case that it is both extremely important and fantastically confusing. Indeed, the ECJ’s initial approach was summed up at the beginning: “For the sake of clarity and given their similarity, certain of the grounds of appeal put forward by the appellants will be considered separately, whilst others will be examined together.” Did someone say “clarity”?

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC004978

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel